For over 40 years, we have been tracking the lives, lifestyles and media habits of Affluent Americans. Insights gleaned from our study are used by hundreds of companies to inform media, marketing and advertising decisions. Join us on August 22.
Are you a subscriber to the Ipsos Affluent Report? If so, then you’re eligible to attend our exclusive subscriber-only panel discussion, on August 8, detailing results from the latest wave of our study as it relates to Affluent Americans’ love affair with cars – particularly vehicles that offer luxury, high-performance, and technological advances.
Overview of the component and service aftermarket
Amazon is combining the “shop local” and “shop online” trends
The world rendez-vous for game changers.
Despite the advent of targeted therapies and the associated rise in the use of companion and complementary diagnostics, we are only just emerging from the initial exploratory stages of oncology biomarker testing. As will be argued in this paper, we are on the cusp of a much more radical revolution, and the molecular diagnostics landscape is set to change dramatically in the coming decades. It is crucial that any company entering this space prepare for this imminent upheaval and plan their launch strategy accordingly.
A challenge that market research is increasingly facing is why, in a world where behavioural science apparently suggests that are limits to what consumers tell us, do we continue to ask questions?
Welcome to the June edition of Ipsos Update – our monthly round-up of research and thinking from Ipsos’ teams around the world.
The expectations of Europeans in terms of mobility.
On June 27, join us to discover the future of path to purchase.